StockData
AtriCure, Inc. logo

AtriCure, Inc. (ATRC) stock

ATRCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/30893% above fair value
$55.45+0.43 (+0.78%)

Close on Nov 18, 2026Market cap $2.82BP/E 264.0Yield –

AtriCure revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

AtriCure's revenue for the twelve months ending Jun 30, 2026 was $569.62M, up 13.9% year over year. For fiscal 2025 it was $534.53M, up 14.9% from the year before. Over ten years it grew 15.2% a year on average. The highest annual figure on record is $534.53M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$534.53M+14.9%
FY2024Dec 31, 2024$465.31M+16.5%
FY2023Dec 31, 2023$399.25M+20.8%
FY2022Dec 31, 2022$330.38M+20.4%
FY2021Dec 31, 2021$274.33M+32.8%
FY2020Dec 31, 2020$206.53M-10.5%
FY2019Dec 31, 2019$230.81M+14.5%
FY2018Dec 31, 2018$201.63M+15.4%
FY2017Dec 31, 2017$174.72M+12.6%
FY2016Dec 31, 2016$155.11M+19.5%
FY2015Dec 31, 2015$129.76M+20.8%
FY2014Dec 31, 2014$107.45M+31.2%
FY2013Dec 31, 2013$81.89M+16.6%
FY2012Dec 31, 2012$70.25M+9.1%
FY2011Dec 31, 2011$64.40M+9.1%
FY2010Dec 31, 2010$59.01M+8.2%
FY2009Dec 31, 2009$54.53M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$153.60M+12.8%
Q1 FY2026Mar 31, 2026$141.25M+14.3%
Q4 FY2025Dec 31, 2025$140.50M+13.1%
Q3 FY2025Sep 30, 2025$134.27M+15.8%
Q2 FY2025Jun 30, 2025$136.14M+17.1%
Q1 FY2025Mar 31, 2025$123.62M+13.6%
Q4 FY2024Dec 31, 2024$124.28M+16.6%
Q3 FY2024Sep 30, 2024$115.91M+17.9%
Q2 FY2024Jun 30, 2024$116.27M+15.2%
Q1 FY2024Mar 31, 2024$108.85M+16.4%
Q4 FY2023Dec 31, 2023$106.54M+21.0%
Q3 FY2023Sep 30, 2023$98.29M+18.1%
Q2 FY2023Jun 30, 2023$100.92M+19.4%
Q1 FY2023Mar 31, 2023$93.49M+25.4%
Q4 FY2022Dec 31, 2022$88.03M+20.2%
Q3 FY2022Sep 30, 2022$83.25M+18.1%
Q2 FY2022Jun 30, 2022$84.53M+18.4%
Q1 FY2022Mar 31, 2022$74.58M+25.8%
Q4 FY2021Dec 31, 2021$73.22M+26.8%
Q3 FY2021Sep 30, 2021$70.46M+28.7%
Q2 FY2021Jun 30, 2021$71.38M+74.8%
Q1 FY2021Mar 31, 2021$59.28M+11.4%
Q4 FY2020Dec 31, 2020$57.73M-5.9%
Q3 FY2020Sep 30, 2020$54.76M-3.3%
Q2 FY2020Jun 30, 2020$40.82M-30.7%
Q1 FY2020Mar 31, 2020$53.23M-1.4%
Q4 FY2019Dec 31, 2019$61.32M+15.9%
Q3 FY2019Sep 30, 2019$56.61M+13.4%
Q2 FY2019Jun 30, 2019$58.91M+13.7%
Q1 FY2019Mar 31, 2019$53.97M+14.8%
Q4 FY2018Dec 31, 2018$52.89M+14.8%
Q3 FY2018Sep 30, 2018$49.94M+18.5%
Q2 FY2018Jun 30, 2018$51.80M+14.5%
Q1 FY2018Mar 31, 2018$46.99M+13.9%
Q4 FY2017Dec 31, 2017$46.06M+11.9%
Q3 FY2017Sep 30, 2017$42.15M+9.9%
Q2 FY2017Jun 30, 2017$45.23M–
Q1 FY2017Mar 31, 2017$41.27M–
Q4 FY2016Dec 31, 2016$41.16M–
Q3 FY2016Sep 30, 2016$38.34M–

More AtriCure figures

See a number that looks wrong?